US FDA approves Astellas combination therapy for bladder cancer
![](https://4gi.tv/wp-content/uploads/2023/12/1812-ws-he-1024x576.jpg)
The US Food and Drug Administration has approved Astellas Pharma’s Padzeva in combination with Merck’s Keytruda for a type of bladder cancer. In April, the FDA granted accelerated approval for the combination to treat patients with the disease who are not indicated for chemotherapy with the widely used anticancer drug cisplatin.
POPULAR POSTS
![](https://4gi.tv/wp-content/uploads/2024/07/2607-02.png)
‘The Kardashians’ renewed by Hulu for 20 more episodes
July 26, 2024
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env2.jpg)
Death toll from landslides in Ethiopia could rise to 500
July 26, 2024
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env1.jpg)
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env.jpg)
The Canadian wildfire has made its way to Jasper
July 26, 2024
LIVE STREAM